Related Experiment Video
Updated: Jul 27, 2026
10:50
Primary Culture of Human Vestibular Schwannomas
Published on: July 20, 2014
Vagal paraganglioma: the Jefferson experience
R B Miller1, M S Boon, J P Atkins
1Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Summary
Vagal paraganglioma, a rare neural crest tumor, presents diagnostic consensus but treatment debate. This study analyzes surgical approaches and nerve-sparing techniques, offering recommendations for managing these complex head and neck tumors.
Area of Science:
- Neuro-oncology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Vagal paraganglioma is a rare tumor originating from neural crest cells.
- While epidemiology and biology are understood, treatment modalities remain debated.
- This study focuses on a single-institution series of 19 patients.
Purpose of the Study:
- To analyze treatment modalities for vagal paraganglioma.
- To evaluate the efficacy and sequelae of vagus nerve-sparing surgical approaches.
- To discuss operative complications, postoperative morbidity, and rehabilitation strategies.
Main Methods:
- Retrospective review of 19 patients diagnosed with vagal paraganglioma.
- Utilized CT scan, MRI, and angiography for diagnosis and treatment planning.
- Analyzed preoperative embolization, surgical approach, and adjunct procedures.
Main Results:
- Investigated general statistics, clinical presentation, and tumor characteristics.
- Examined the role of preoperative embolization in recent cases.
- Presented findings on vagus nerve-sparing procedures, complications, and rehabilitation.
Conclusions:
- Offers recommendations for vagal paraganglioma treatment based on a single-institution experience.
- Highlights the importance of nerve-sparing techniques and adjunct procedures for functional outcomes.
- Contributes to the ongoing discussion on optimal management strategies for this rare tumor.
Related Concept Videos
01:21Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...